Anti-TNF biologics are a class of medications that target TNF directly as monoclonal antibodies or the TNF receptor to block the cytokine cascade and successfully modify disease activity in a milieu of rheumatic diseases (e.g., RA, JIA, uveitis) (83, 84). This evidence concerns the gene TNF and rheumatoid arthritis.